Gregory W. Schafer

This profile gathers the share dealings of Gregory W. Schafer across 3 companies, led by Chinook Therapeutics, Inc., Onyx Pharmaceuticals Inc and Capricor Therapeutics, Inc. In total, 58 filings cover trades dated from 11 August 2006 to 25 January 2018.

On the open market, the record shows 2 purchases worth €27k and 23 sales worth €5.1M. On balance, insiders were net sellers of €5.0M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 5 share grants and 27 option exercises. So far in 2018, the count stands at no purchases and 1 sale.

The newest entry dates from 26 January 2018: an option exercise of €40k, in Chinook Therapeutics, Inc. The last insider purchase was made public on 16 April 2008, 6,780 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.